Committee
PRESIDENT & PUBLIC AFFAIRS EXTERNAL RELATIONS LEAD:
Professor Graham Foster, Consultant Hepatologist, Barts and the London
Professor of Hepatology at Barts and The London School of Medicine and a consultant hepatologist at Barts and The London NHS Trust in East London, he trained in Medicine at Oxford and London Universities in the 1980s and completed a PhD in Molecular Biology in 1992. Professor Foster has a long-standing interest in the management of chronic viral hepatitis and runs a clinical research program studying the natural history of viral hepatitis, its impact upon patients and their communities and novel therapies for this disease. He also supervises a laboratory research program investigating the mode of action of the different type I interferons. He is a member of a number of patient advocacy groups and is a member of the UK Department of Health Advisory Group on Hepatitis.
SECRETARY:
Dr Philip Harrison, Consultant Hepatologist, Kings College Hospital
Dr Phil Harrison qualified from St George’s Hospital Medical School in 1984. He trained in Hepatology at King’s College Hospital, London and Addenbrooke’s Hospital, Cambridge, and was awarded MD by the University of London in 1992. Subsequently he studied for a PhD in molecular and cell biology in the Department of Molecular Medicine at King’s. In 1994 he was appointed as Senior Lecturer and Consultant Hepatologist at King’s. He joined London Bridge Hospital as a Consultant Hepatologist in 1996.
TREASURER:
Dr Matthew Cramp, Consultant Hepatologist, Derriford Hospital
Dr Matthew Cramp is a Consultant Hepatologist at Derriford Hospital in Plymouth, an Honorary Reader at the Peninsula Medical School and Clinical Director of the Peninsula Hepatology Network. His research interests include involvement in many clinical trials of HCV treatment and study of potential immunological and genetic mechanisms of protection from HCV infection.
EDUCATION & TRAINING LEADS:
Dr Mark Hudson, Freeman Hospital, Newcastle - BASL Education and Training Committee
Dr Mark Hudson is Consultant Hepatologist and Transplant Hepatologist in the Liver Unit, Freeman Hospital, Newcastle upon Tyne. Main areas of clinical and research interest are acute liver failure and liver transplantation, portal hypertension and primary sclerosing cholangitis.
Dr Bill Griffiths, Addenbrookes, Cambridge
Dr Bill Griffiths is a Consultant Hepatologist at Addenbrooke's Hospital with specific involvement in the tertiary hepatology and liver transplant service. His main research interest is haemochromatosis and adult metabolic liver disease. Clinical interests also include EUS, ERCP and biliary disease. Dr Griffiths is responsible for Hepatology training in the East of England region.
BVHG CHAIRMEN:
Dr Ashley Brown, Imperial College London
Ashley Brown graduated from Liverpool Medical School in 1988. He completed his postgraduate training at the Liver Unit in the Freeman Hospital, Newcastle-upon-Tyne, and he was later awarded and MD from the University of Newcastle for research into the pharmacogenetics of alcoholic liver disease. He has worked as a consultant on a number of Liver Units in the UK and Australia, and is currently Consultant Hepatologist at St Mary's and Hammersmith hospitals, London and Honorary Senior Lecturer at Imperial College, London. His major clinical interests include the treatment of viral hepatitis, liver transplantation and liver cancer.
RESEARCH LEAD:
Dr Graeme Alexander, Cambridge University Hospitals
Graeme Alexander graduated in 1976 from Bristol University after obtaining MRCP moved to join Roger Williams and Adrian Eddleston at the liver unit at King’s College Hospital. After a brief 10 year stay he moved to Addenbrooke’s Hospital Cambridge to establish a new hepatology service to support the liver transplant programme there.
SURGERY SPECIALIST:
Professor Derek Manas, Consultant HPB and Transplant Surgeon
Derek Manas is a consultant Hepatobiliary and Transplant Surgeon and Director of the Transplant Institute at Newcastle-upon-Tyne NHS Hospital Trust and Professor of Organ Transplantation at the University of Newcastle upon Tyne. He has an interest in Liver Cancer, both primary and metastatic - with a special interest in treatment of HCC and Hilar Choloangio Carcinomna - and new treatment modalities.
SERVICES LEAD:
Geoffrey Dusheiko, MD, MB,BCh FCP(SA) FRCP FRCP (Edin)
Geoffrey Dusheiko, MD, MB,BCh, is a professor of medicine at the Royal Free Hospital and University College School of Medicine, London, UK. He earned his bachelor of medicine, bachelor of surgery degree from the University of Witwatersrand in Johannesburg, South Africa. After graduating, he completed his internship at Baragwanath Hospital in Johannesburg and his residency at Johannesburg Hospital. His fellowships were conducted at the Johannesburg Hospital Liver Unit and the National Institutes of Health in Maryland and the University of Minnesota (United States). Dr. Dusheiko's research interests include the management and treatment of hepatitis B and C and small hepatocellular carcinoma; he has a special interest in research in viral hepatitis, focused on viral genotyping, applied molecular virology, the natural history of chronic viral hepatitis, and antiviral therapies. He has served on editorial boards for the Journal of Viral Hepatitis, Hepatology, and Best Practice and Research: Clinical Gastroenterology, GUT among others, and is the author of more than 290 published articles. A member of several organizations, including IASL, AASLD, and EASL, he is a fellow of the Royal College of Physicians, the Royal College of Physicians of South Africa, and the Royal College of Physicians of Edinburgh. He has served on the Governing Board of the European Association for the Study of the Liver for the past 4 years.